Advertisement

World Journal of Urology

, Volume 37, Issue 12, pp 2677–2682 | Cite as

En bloc resection improves the identification of muscularis mucosae in non-muscle invasive bladder cancer

  • Hua Liang
  • Tao Yang
  • Kaijie Wu
  • Dalin HeEmail author
  • Jinhai FanEmail author
Original Article

Abstract

Purpose

The T1 substage, according to the relationship between muscularis mucosae (MM) and tumors, is a promising prognostic factor for T1 bladder cancer. However, the identification rate of MM is low in specimens, and it is, therefore, not widely used in clinical practice. In this study, we investigated whether en bloc resection of non-muscle invasive bladder cancer (NMIBC) could improve the identification of muscularis mucosae (MM), which may further accurate identification of the T1 substage.

Patients and methods

Specimens from 158 patients with primary NMIBC were retrospectively reviewed by two independent pathologists to assess the presence of MM and stratify the T1 substage. Of 158 specimens, 70 specimens were obtained via TURBt with a plasma kinetic loop and 88 were obtained via front-firing potassium-titanyl-phosphate (KTP) green-light laser en bloc resection. Univariable and multivariable logistic regression models were used to analyze the relationship between the clinical characteristics and the presence of MM.

Results

The mean age was 58.22 years (range 18–85 years). Multivariable logistic regression analysis showed that the KTP laser resection method was associated with the presence of MM in specimens (P = 0.008). In addition, tumors with smaller sizes, which could also be en bloc resected with TURBt (e.g., ≤1 cm), had a higher presence of MM (P = 0.047).

Conclusions

En bloc resection improves the identification rate of MM, which may enhance the accurate identification of the T1 substage.

Keywords

T1 substage En bloc resection Muscularis mucosae Non-muscle invasive bladder cancer 

Notes

Acknowledgements

This study was supported by the National Natural Science Foundation of China (No: 81572520) and the Clinical Research Award of the First Affiliated Hospital of Xi'an Jiaotong University, China (No: XJTU1AF–CRF-2015–002 to DH) and International cooperation project of Shanxi, China (No: S2016YFKW0042). The authors appreciate Prof. Guanjun Zhang, from the Department of Pathology, the First Affiliated Hospital of Xi’an Jiaotong University, for help in this paper.

Author contributions

JHF: perform operation, project development, and manuscript editing. HL: data collection, manuscript writing, view pathological specimens. TY: data collection and manuscript writing. KJW: project development and manuscript writing. DLH: manuscript editing.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

For this type of study, formal consent is not required.

References

  1. 1.
    Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424CrossRefGoogle Scholar
  2. 2.
    Sylvester RJ, van der Meijden AP, Oosterlinck W, Witjes JA, Bouffioux C, Denis L, Newling DW, Kurth K (2006) Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 596 patients from seven EORTC trials. Eur Urol 49:465–466 (475–477)CrossRefGoogle Scholar
  3. 3.
    Xylinas E, Kent M, Kluth L, Pycha A, Comploj E, Svatek RS, Lotan Y, Trinh QD, Karakiewicz PI, Holmang S et al (2013) Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder. Br J Cancer 109:1460–1466CrossRefGoogle Scholar
  4. 4.
    Dixon JS, Gosling JA (1983) Histology and fine structure of the muscularis mucosae of the human urinary bladder. J Anat 136:265–271PubMedPubMedCentralGoogle Scholar
  5. 5.
    Ro JY, Ayala AG, El-Naggar A (1987) Muscularis mucosa of urinary bladder. Importance for staging and treatment. Am J Surg Pathol 11:668–673CrossRefGoogle Scholar
  6. 6.
    Keep JC, Piehl M, Miller A, Oyasu R (1989) Invasive carcinomas of the urinary bladder. Evaluation of tunica muscularis mucosae involvement. Am J Clin Pathol 91:575–579CrossRefGoogle Scholar
  7. 7.
    Fransen VDPE, Behrendt MA, Pigot GL, van der Kwast TH, van Rhijn BW (2015) Prognostic significance of substage and WHO classification systems in T1 urothelial carcinoma of the bladder. Curr Opin Urol 25:427–435CrossRefGoogle Scholar
  8. 8.
    He D, Fan J, Wu K, Wang X, Wu D, Li L, Li X, Liu L, Cao P, Cao J et al (2014) Novel green-light KTP laser en bloc enucleation for nonmuscle-invasive bladder cancer: technique and initial clinical experience. J Endourol 28:975–979CrossRefGoogle Scholar
  9. 9.
    Martin-Doyle W, Leow JJ, Orsola A, Chang SL, Bellmunt J (2015) Improving selection criteria for early cystectomy in high-grade t1 bladder cancer: a meta-analysis of 15,215 patients. J Clin Oncol 33:643–650CrossRefGoogle Scholar
  10. 10.
    Brimo F, Wu C, Zeizafoun N, Tanguay S, Aprikian A, Mansure JJ, Kassouf W (2013) Prognostic factors in T1 bladder urothelial carcinoma: the value of recording millimetric depth of invasion, diameter of invasive carcinoma, and muscularis mucosa invasion. Hum Pathol 44:95–102CrossRefGoogle Scholar
  11. 11.
    Cheng L, Weaver AL, Neumann RM, Scherer BG, Bostwick DG (1999) Substaging of T1 bladder carcinoma based on the depth of invasion as measured by micrometer: A new proposal. Cancer 86:1035–1043CrossRefGoogle Scholar
  12. 12.
    Cheng L, Neumann RM, Weaver AL, Spotts BE, Bostwick DG (1999) Predicting cancer progression in patients with stage T1 bladder carcinoma. J Clin Oncol 17:3182–3187CrossRefGoogle Scholar
  13. 13.
    van Rhijn BW, van der Kwast TH, Alkhateeb SS, Fleshner NE, van Leenders GJ, Bostrom PJ, van der Aa MN, Kakiashvili DM, Bangma CH, Jewett MA et al (2012) A new and highly prognostic system to discern T1 bladder cancer substage. Eur Urol 61:378–384CrossRefGoogle Scholar
  14. 14.
    Colombo R, Hurle R, Moschini M, Freschi M, Colombo P, Colecchia M, Ferrari L, Luciano R, Conti G, Magnani T et al (2016) Feasibility and Clinical Roles of Different Substaging Systems at First and Second Transurethral Resection in Patients with T1 High-Grade Bladder Cancer. Eur Urol Focus 4(1):87–93CrossRefGoogle Scholar
  15. 15.
    Herrmann TR, Wolters M, Kramer MW (2017) Transurethral en bloc resection of nonmuscle invasive bladder cancer: trend or hype. Curr Opin Urol 27:182–190CrossRefGoogle Scholar
  16. 16.
    Karl A, Herrmann TR (2015) En bloc resection of urothelial cancer within the urinary bladder: the upcoming gold standard? : Re: Kramer MW, Wolters M, Cash H, Jutzi S, Imkamp F, Kuczyk MA, Merseburger AS, Herrmann TR. Current evidence of transurethral Ho:YAG and Tm:YAG treatment of bladder cancer: update 2014. World J Urol. 2014 Jun 10. [Epub ahead of print].  https://doi.org/10.1007/s00345-014-1337-y. World J Urol 33: 581–582CrossRefGoogle Scholar
  17. 17.
    Chen J, Zhao Y, Wang S, Jin X, Sun P, Zhang L, Wang M (2016) Green-light laser en bloc resection for primary non-muscle-invasive bladder tumor versus transurethral electroresection: a prospective, nonrandomized two-center trial with 36-month follow-up. Lasers Surg Med 48:859–865CrossRefGoogle Scholar
  18. 18.
    Cheng B, Qiu X, Li H, Yang G (2017) The safety and efficacy of front-firing green-light laser endoscopic en bloc photoselective vapo-enucleation of non-muscle-invasive bladder cancer. Ther Clin Risk Manag 13:983–988CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of UrologyThe First Affiliated Hospital of Xi’an Jiaotong UniversityXi’anPeople’s Republic of China
  2. 2.Department of PathologyThe First Affiliated Hospital of Xi’an Jiaotong UniversityXi’anPeople’s Republic of China

Personalised recommendations